VREX (Varex Imaging) Marketable Securities: $3.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VREX Varex Imaging Corp VREX
69 GF Score
Price $10.94
GF Value $14.02
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Varex Imaging Marketable Securities?

Varex Imaging VREX +1.82% 69 Marketable Securities is $3.0 Mil as of Mar. 2026. GuruFocus rates VREX with a GF Score™ of 69/100 and a GF Value™ of $14.02 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Varex Imaging's Marketable Securities for the quarter that ended in Mar. 2026 was $3.0 Mil.

Varex Imaging's annual Marketable Securities declined from Sep. 2023 ($41.3 Mil) to Sep. 2024 ($31.8 Mil) and declined from Sep. 2024 ($31.8 Mil) to Sep. 2025 ($10.1 Mil).

Varex Imaging  (NAS:VREX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Varex Imaging Marketable Securities Related Terms

Varex Imaging Marketable Securities Historical Data

* Premium members only.

The historical data trend for Varex Imaging's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Varex Imaging Marketable Securities Chart

Varex Imaging Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 41.30 31.80 10.10

Varex Imaging Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.90 16.20 10.10 6.10 3.00
VREX
69GF Score
Varex Imaging Corp VREX
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Varex Imaging Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $3.0 Mil mean?
Varex Imaging (VREX) has a Marketable Securities of $3.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Varex Imaging and its competitors.
Is Varex Imaging's Marketable Securities too high?
Varex Imaging's current Marketable Securities is $3.0 Mil. Overall, Varex Imaging has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Varex Imaging's Marketable Securities compare to VMD and DCTH?
Varex Imaging's Marketable Securities of $3.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Varex Imaging and its competitors. Varex Imaging's current Marketable Securities is $3.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Varex Imaging stock overvalued right now?
Based on GuruFocus' analysis, Varex Imaging (VREX) is currently considered Modestly Undervalued. The stock's GF Value™ is $14.02, compared to a current price of $10.94 — trading 22% below its estimated fair value. The current Marketable Securities is $3.0 Mil. Varex Imaging's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Varex Imaging (VREX), the current Marketable Securities is $3.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Varex Imaging (VREX) Overvalued in 2026?

Based on GuruFocus' analysis, Varex Imaging stock appears to be undervalued. The current stock price of $10.94 is trading 22% below its estimated GF Value™ of $14.02. GuruFocus considers Varex Imaging to be Modestly Undervalued.

Key valuation signals for VREX:

  • Marketable Securities: $3.0 Mil
  • GF Value™: $14.02 vs. price of $10.94 (22% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the VREX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Varex Imaging Business Description

Address 1678 S. Pioneer Road, Salt Lake City, UT, USA, 84104
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
69GF Score

Get the complete analysis for VREX

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.94
Price
$14.02
GF Value